CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. – Ultragenyx Pharmaceutical Inc. Transaction History
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. portfolio value:
$7.80M
portfolio value
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. quarter portfolio value change:
-30.59%
quarter
Ultragenyx Pharmaceutical Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +478.32% | 155.84K shares | 5.85M | $41.41 | 188.42K |
| Q2 2022 | share | Increase | 0.00% | 32.58K shares | 1.94M | $59.66 | 32.58K |
| Q3 2021 | share | Decrease | -100.00% | -2.35K shares | -225K | $90.19 | 0 |
| Q2 2021 | share | Decrease | -84.76% | -13.10K shares | -1.53M | $95.35 | 2.35K |
| Q1 2021 | share | Increase | +488.96% | 12.84K shares | 1.39M | $113.86 | 15.46K |
| Q4 2020 | share | Increase | 0.00% | 2.62K shares | 364K | $138.43 | 2.62K |